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ABSTRACT
Lens epithelium-derived growth factor p75 (LEDGF/
p75) is a DNA-binding, transcriptional co-activator
that participates in HIV-1 integration site targeting.
Using complementary approaches, we determined
the mechanisms of LEDGF/p75 DNA-binding in vitro
and chromatin-association in living cells. The binding
of highly-purified, recombinant protein was assayed
by surface plasmon resonance (SPR) and electro-
phoretic mobility gel shift. Neither assay revealed evi-
dence for sequence-specific DNA-binding. Residues
146–197 spanning the nuclear localization signal
(NLS) and two AT-hook motifs mediated non-
specific DNA-binding, and DNA-binding deficient
mutants retained the ability to efficiently stimulate
HIV-1 integrase activity in vitro. Chromatin-
association was assessed by visualizing the locali-
zation of EGFP fusion proteins in interphase and
mitotic cells. Although a conserved N-terminal
PWWP domain was not required for binding to
condensed mitotic chromosomes, its deletion subtly
affected the nucleoplasmic distribution of the protein
during interphase. A dual AT-hook mutant associated
normally with chromatin, yet when the mutations were
combined with NLS changes or deletion of the PWWP
domain, chromatin-binding function was lost. As the
PWWP domain did not readily bind free DNA in vitro,
our results indicate that chromatin-association is
primarily affected through DNA-binding, with the
PWWP domain likely contributing a protein inter-
action to the overall affinity of LEDGF/p75 for
human chromatin.
INTRODUCTION
Transcriptional co-activators play important roles in regula-
ting gene expression in higher eukaryotes. Some, like acetyl-
transferases, are enzymes that directly modify chromatin.
Other co-activators lack enzyme function and effect transcrip-
tion by interacting with the general transcription apparatus
[reviewed in ref. (1)]. Transcriptional co-activator p75, also
known as lens epithelium-derived growth factor (LEDGF), fits
in this latter category. A member of the hepatoma-derived
growth factor (HDGF) family of proteins, LEDGF/p75 and
its smaller splice-variant LEDGF/p52 were identified as
activities that co-purified with the PC4 general transcriptional
co-activator (2).
LEDGF/p75 can affect cellular or organismal physiology.
Its expression can protect cells from stress-induced apoptosis
(3,4). Elevated levels of the protein are observed in some
prostate cancers (5) and relatively rare cases of acute and
chronic myeloid leukemia harbor NUP98-PSIP1 transloca-
tions that predictably express NUP98–LEDGF/p75 fusion
proteins (6–8). LEDGF/p75 is a nuclear protein that intimately
associates with chromatin (9–11) and like other chromatin-
binding proteins, antibodies to LEDGF/p75 occur in some
autoimmune diseases [reviewed in ref. (12)]. However the
regions and amino acid residues of LEDGF/p75 that mediate
chromatin-association are unknown. In this study, we identify
the LEDGF/p75 determinants that effect its interaction with
chromatin in live cells.
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Partial proteolysis and sequence analyses previously
revealed two 10 kDa structured domains within the
530-residue human protein: an N-terminal PWWP domain
(residues 1–93) that is present in a variety of chromatin-
associated proteins (13,14) and an integrase-binding domain
(IBD, residues 347–429) that occurs in one other HDGF
family member, HDGF-related protein 2 (15,16). LEDGF/
p75 binds to DNA in vitro (17,18) and as a prelude to
cell-based experiments, the regions and amino acid residues
that mediate DNA-binding were mapped using surface plas-
mon resonance (SPR) and electrophoretic mobility shift assay
(EMSA). Unlike previous reports (17), the preferential binding
of purified LEDGF/p75 protein to specific DNA sequences
was not detected. The nuclear localization signal (NLS)
(16,19) and a nearby dual copy of the AT-hook DNA-binding
motif (20) mediate LEDGF/p75 non-specific DNA activity
in vitro. The PWWP domain is dispensable for binding to
naked DNA, but functions together with the NLS and
AT-hooks to effect the interaction with chromatin in cells.
LEDGF/p75 is a dominant cellular binding partner of HIV-1
integrase (10,11,19,21–24) and potently stimulates the in vitro
activities of the viral enzyme (10,15,25). More recently,
LEDGF/p75 was shown to play a role in targeting HIV-1 to
active gene regions and A/T-rich sequences during integration
(26). LEDGF/p75 mutant proteins defective for DNA-binding,
integrase-binding or both activities were analyzed for stimu-
lation of integrase activity using a novel real-time PCR-based
integration assay. As the results of these assays discount an
important role for DNA-binding in stimulating integrase func-
tion, we infer that the ability for LEDGF/p75 to target HIV-1
to A/T-rich sequences and active genes is separable from its
integrase-stimulatory activity.
MATERIALS AND METHODS
Plasmid constructs
Deletion mutants were expressed in bacteria as fusions
to glutathione S-transferase (GST) using pGEX-6P3-based
vectors (Amersham Biosciences). Sense primers for truncated
LEDGF coding sequences were tagged at their 50 ends
with a BamHI site, followed by an initiating ATG codon.
DNA fragments amplified by PCR from pCP-Nat75 (11)
using PfuUltra DNA polymerase (Stratagene) were digested
with BamHI and ligated with BamHI/SmaI-digested vector
DNA. Full-length LEDGF/p75 and missense variants were
expressed from pFT-1-LEDGF (27) as fusions to an
N-terminal hexahistidine (His6) tag. Mutations were intro-
duced into pFT-1-LEDGF by QuikChange mutagenesis
(Stratagene).
For mammalian cell-expression, sequences were ampli-
fied from corresponding pFT-1-LEDGF constructs using
PfuUltra polymerase and either 50-GCGCAGATCTCGAT-
GACTCGCGATTTCAAAC (sense primer for full-length
constructs) or 50-GCGCAGATCTCGTCAAGTGAACAGG-
CAGCAAC (sense primer for PWWP deletion constructs)
and 50-CGCGAATTCCTAGTTATCTAGTGTAGAATCC
(antisense primer for all constructs). The underlined sequences
are BglII and EcoRI restriction sites in sense and antisense
primers, respectively. BglII/EcoRI-digested fragments were
ligated with BglII/EcoRI-digested pEGFP-C2 (Clontech).
The initial 116 codons of LEDGF/p75 were fused to enhanced
green fluorescent protein (EGFP) to create EGFP-PWWP. The
sequences of all plasmids that were derived by PCR in this
study were verified by DNA sequencing.
Expression and purification of recombinant proteins
GST-LEDGF proteins expressed in BL21 cells were purified
by a two-step procedure as described previously (15)
with slight modifications. Bacteria were grown at 30C to
OD600 0.8–0.9, protein expression was induced by adding
isopropyl-thio-b-D-galactopyranoside (IPTG) to 0.5 mM,
followed by growth at 37C for 2 h. Harvested bacterial
pellets were frozen at 80C, and thawed cells were resus-
pended in buffer containing 500 mM NaCl, 1 mM EDTA,
0.5 mM phenylmethylsulfonyl fluoride (PMSF), 2 mM
DTT, 50 mM Tris–HCl (pH 7.2). Sonicated lysates clarified
by centrifugation were injected on to a GSTrap HP
column (Amersham Biosciences), and bound proteins were
eluted with 500 mM NaCl, 25 mM reduced glutathione,
50 mM Tris–HCl (pH 7.7). Peak fractions were pooled and
the GST-tag was removed by overnight digestion at 4C
with 4 U of PreScission Protease per mg of protein. Cleaved
protein diluted 5-fold with 50 mM NaH2PO4 (pH 7.2)
to reduce NaCl concentration was injected on to a HiTrap
SP Sepharose column (Amersham Biosciences), followed
by elution with a linear gradient of NaCl from 0.2 to 1 M
in 50 mM NaH2PO4. If necessary, pooled LEDGF fractions
were further purified by gel filtration chromatography using
a Superdex 200 column (Amersham Biosciences) in
100 mM NaCl, 50 mM NaH2PO4 (pH 7.2). Fractions contain-
ing purified protein were pooled, concentrated by ultrafiltra-
tion using Centricon-10 (Millipore Corp.), supplemented
with 10% (w/v) glycerol, flash frozen in liquid N2 and stored
at 80C.
His6-tagged LEDGF/p75 expressed in BL21(DE3)pLysS
cells (Novagen, Inc.) was purified using three chromatography
steps. Cells grown at 32C to OD600 0.8–0.9 were induced by
adding IPTG to 0.5 mM, followed by growth at 28C for 4 h.
Bacterial pellets were frozen, and thawed cells were lysed in
buffer containing 1 M NaCl, 0.5 mM PMSF, 15 mM imida-
zole, 25 mM Tris–HCl (pH 7.4) in the presence of EDTA-free
Complete protease inhibitor (Roche Molecular Biochemicals).
Sonicated lysates clarified by centrifugation were incubated in
batch with Ni-nitrilotriacetate agarose beads (QIAGEN) for 1 h
at 4C. Bound proteins were eluted with 1 M NaCl, 200 mM
imidazole, 25 mM Tris–HCl (pH 7.4). Peak fractions were
pooled and the His6-tag was removed by overnight digestion
with PreScission Protease as described above. LEDGF was
further purified by cation-exchange chromatography as
described above for deletion mutant proteins. Pooled
LEDGF-containing fractions were then purified by gel filtra-
tion chromatography (Superdex 200) in 120 mM NaCl, 25 mM
Tris–HCl (pH 7.4). Fractions containing purified protein were
pooled, concentrated, frozen and stored as above. Protein con-
centrations were determined by the Bio-Rad protein assay using
BSA as a standard. Protein purity was analyzed using
Coomassie-stained images and Quantify One version 4.1.1
software (Bio-Rad Laboratories). Non-tagged LEDGF/p75
and GST were purified as described (15); RNase A was
purchased from QIAGEN.
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SPR
Double-stranded oligonucleotides were constructed from
high performance liquid chromatography (HPLC)-purified
single-strands (Integrated DNA Technologies). AE2019 (50-
biotin-GATTTAACGAGAGAAGGTTCCAGA), AE2042
(50-biotin-GATTTAACTAAATAAATTTTAAAA), AE2043
(50-biotin GATTTAACGAGATAATTTTACAGA), AE1198
(50-TCTGGAACCTTCTCTCGTTAA), AE2000 (50-TTTTA-
AAATTTATTTAGTTAA) and AE2002 (50-TCTGTAAAAT-
TATCTCGTTAA) were used for SPR. AE1198 annealed to
AE2019 yielded the 21 bp consensus heat shock element
(HSE) sequence that supported LEDGF/p75 binding, whereas
AE2000/AE2042 and AE2002/AE2043 yielded Mut1 and
Mut2 derivatives, respectively, which reportedly failed to
bind LEDGF/p75 (17). Biotinylated strands were 24 bases
to incorporate GAT single-strand linkers.
SPR was performed on a BIAcore 3000 instrument (Biacore
International AB) at 25C. A streptavidin-coated SA sensor
chip was washed with running buffer [140 mM NaCl, 0.005%
(v/v) surfactant P20, 10 mM HEPES (pH 7.4)] for 30 min, then
exposed to three consecutive, 1 min injections of conditioning
buffer (1 M NaCl, 50 mM NaOH) at a flow rate of 10 ml/min.
Biotinylated oligonucleotides (25 nM) were injected at 5 ml/
min for 1 min, which reproducibly yielded 150 response
units (RU). Complementary strands (25 nM) were injected
until the observed response equaled that of the biotinylated
strand, giving rise to a homogeneous surface of double-
stranded DNA. Typically, 3 of the 4 chip channels were
primed with DNA, with the other serving as a reference to
determine aspecific levels of LEDGF/p75 binding in the
absence of DNA.
Wild-type or mutant LEDGF/p75 (25 nM) was injected
using the KINJECT command with an association phase of
60 s or 120 s (for kinetics measurements) and a dissociation
phase ranging from 5 to 30 min. A flow rate of 30 ml/min
was used to minimize mass transport and rebinding effects.
Following each protein injection, the chip surface was regen-
erated with three injections of conditioning buffer, followed
by reannealing of non-biotinylated complementary strands.
Similar levels of double-stranded DNA immobilization
were reproducibly achieved after each cycle of annealing/
protein injection/chip stripping. Data were analyzed using
BIAevaluation software version 4.0.1 (Biacore Inter-
national AB).
EMSA
The 50 ends of AE1197 (50-TTAACGAGAGAAGGTTCCA-
GA), AE1199 (50-TTAACTAAATAAATTTTAAAA) and
AE2001 (50-TTAACGAGATAATTTTACAGA) were labeled
with T4 polynucleotide kinase (Amersham Biosciences) and
complementary strands (see above) were annealed as
described (28) to yield 21 bp blunt-ended DNAs.
DNA-binding reactions (15 ml) contained 120 mM NaCl,
5 mM MgCl2, 2 mM DTT, 10% glycerol, 50 mg/ml BSA,
100 nM DNA, 25 mM Tris–HCl (pH 7.4) and 80 ng/ml
poly dIdC (Amersham Biosciences) as non-specific competi-
tor. LEDGF proteins diluted in 120 mM NaCl, 25 mM
Tris–HCl (pH 7.4) were added last, and binding proceeded
for 30 min at room temperature. Reactions (without the
addition of sample buffer) were fractionated on 4% Metaphor
agarose gels (Cambrex Bio Science) supplemented to contain
0.1 mg/ml heparin (29). Electrophoresis was for 2.5 h at 4C in
0.5· TBE (44.5 mM Tris base, 44.5 mM borate, 1 mM EDTA)
supplemented with 0.1 mg/ml heparin. Dried gels were visu-
alized and quantified by PhosphorImager using ImageQuant
v1.11 (Amersham Biosciences).
Supershift experiments were conducted by preincubating
LEDGF/p75 (2 mM) with 100 nM DNA at room temperature
for 5 min. Incubation proceeded for 30 min after adding
2.25 mg of mouse anti-LEGDF/p75 monoclonal antibody
(BD Biosciences) or purified IgG1 isotype control (Sigma–
Aldrich Corp.). Electrophoresis was for 7.5 h.
Cell transfection, western blot and confocal microscopy
HeLa cells were maintained in DMEM supplemented with
10% fetal calf serum (FCS), 100 IU/ml penicillin and
100 mg/ml streptomycin. For blotting, cells plated in 6 well
dishes to reach confluency were transfected with 4 mg plasmid
using Lipofectamine 2000 (Invitrogen Corp.). Twenty-four
hours thereafter, cells were harvested, washed twice with
phosphate-buffered saline and lysed in buffer containing
25 mM Tris–HCl (pH 7.4), 400 mM NaCl, 0.01% (v/v)
NP-40, 0.1% (w/v) SDS, 0.1 mM PMSF and EDTA-free
Complete protease inhibitor (Roche Molecular Biochemicals).
Protein concentration was determined using the BCA protein
assay (Pierce Biotechnology Inc.) and 15 mg fractionated on
4–20% Tris-Glycine Gels (Invitrogen Corp.) were electroblot-
ted on to polyvinylidene difluoride membranes. Anti-EGFP
antibody (BD Biosciences) was used at 1:5000 and secondary
horseradish peroxidase (HRP)-conjugated goat anti-rabbit
antibody (Dakocytomation California Inc.) at 1:10 000.
Blots were developed with the ECL + chemiluminescent
HRP substrate (Amersham Biosciences).
For confocal microscopy, cells were plated at 2 · 105 cells/
well in a 24 well plate 24 h prior to transfection. Cells were
transfected as above with 800 ng plasmid and 24 h later, cells
were trypsinized and seeded into 8-well LabTek chambered
cover glass cuvettes (Nalge Nunc International, NY) at 60%
confluency. Live images were obtained using a Nikon C1
Laser Confocal Microscope 24 h thereafter. The cell perme-
able DNA stain DRAQ5 (Alexis Biochemicals) (1 mM)
was added immediately before data acquisition. All images
were acquired at 1024 · 1024 resolution using a 60· water
immersion objective. EGFP was excited at 488 nm and
DRAQ5 at 633 nm.
In vitro integration assays
Recombinant HIV-1 integrase was purified as described
previously (15). Integration reactions (40 ml) contained
300 ng linearized mini-HIV substrate DNA (30), 0.6 mM
integrase, 110 mM NaCl, 5 mM MgCl2, 10 mM DTT,
4 mM ZnCl2, 10 mM HEPES (pH 7.5). Wild-type or mutant
LEDGF/p75 was used at 0.2 mM. For quantitative analyses,
300 ng supercoiled pTZ18U/PL (31) was added as target
DNA. After 90 min at 37C, reactions stopped by addition
of 25 mM EDTA and 0.5% SDS were deproteinized using
10 mg of proteinase K at 37C for 30 min. Reaction products
recovered by precipitation with ethanol were resuspended in
20 ml TE buffer [10 mM Tris–HCl (pH 8), 1 mM EDTA]. DNA
(10 ml) fractionated through 0.8% agarose gels in TAE buffer
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(40 mM Tris base, 20 mM acetate, 1 mM EDTA) was detected
by staining with ethidium bromide.
Integration into pTZ18U/PL was quantified by real-time
PCR using HIV-1 U5 primer AE2397 (50-GGTTAGACCA-
GATCTGAGCCTGGGAG) and target DNA primers AE2315
(50-CTACTTACTCTAGCTTCCCGGCAAC) and AE2316
(50-TTCGCCAGTTAATAGTTTGCGCAAC). Reactions
(30 ml) containing 1 ml of a 1:100 dilution of DNA, 0.3 mM
of each primer and QuantiTect SYBR Green PCR Kit
(QIAGEN) components were cycled in a DNA Engine
Opticon thermal cycler (MJ Research Inc.) using 20 s of
denaturation at 94C, 20 s of annealing at 58C and 45 s of
extension at 72C. A standard curve was generated for each set
of integration reactions by serially diluting the wild-type
LEDGF/p75-containing sample prior to PCR. Results were
analyzed using OpticonMONITOR Analysis Software
version 2.01 supplied by the manufacturer.
RESULTS
Characterization of the in vitro DNA-binding activity of
LEDGF/p75
LEDGF/p75 was reported to bind consensus HSE (nGAAn)
and stress-related element [STRE; (T/A)GGGG(A/T)] DNA
sequences in the promoter regions of stress-related genes
(3,17,32). To characterize the region(s) of LEDGF/p75
responsible for DNA-binding, a set of three previously
described 21 bp oligonucleotide substrates were utilized.
LEDGF/p75 reportedly bound to the HSE substrate (which
contains two GAA motifs) in a polyacrylamide gel-based
EMSA, whereas Mut1 and Mut2, containing either TAA or
AAA in place of GAA (Figure 1A), failed to support
detectable binding (17).
SPR was initially used to study DNA-binding. Unlike
gel-based EMSAs, SPR can monitor molecular interactions
Figure 1. LEDGF/p75 binds to various DNA sequences in vitro. (A) Sequences of 21 bp substrates. The HSE sequence, containing two 50-GAA motifs (underlined),
has a G/C content of 47%. Mut1 (5% G/C rich) and Mut2 (24% G/C rich) were derived from HSE by mutating G or C residues to A or T (17). Altered residues are in
bold type. (B) Binding of LEDGF/p75 to DNA as determined by SPR. The response for each substrate is plotted as a function of time. Values obtained from a blank
streptavidin-coated surface were subtracted from DNA-dependent signals. Similar results were obtained over multiple (more than a dozen) independent experiments.
(C) A subset of the LEDGF proteins used in this study. Approximately 2 mg of the following purified proteins were detected by staining with Coomassie blue
following polyacrylamide gel electrophoresis: lane 1, non-tagged wild-type LEDGF/p75; lane 2, PreScission Protease-treated wild-type LEDGF/p75; lane 3, 347–
530; lane 4, 1–116; lane 5, 93–226; lane 6, MutL1; lane 7, MutL3; lane 8, MutL4; lane 9, MutL5. The migration positions of molecular mass standards in kDa are
shown next to the gel. (D) LEDGF/p75 DNA-binding as determined by EMSA. The reactions in lanes 2, 9 and 16 contained 125 nM LEDGF/p75. Lanes 3, 10 and 17
contained 250 nM LEDGF/p75; lanes 4, 11 and 18, 500 nM; lanes 5, 12 and 19, 1 mM; lanes 6, 13 and 20, 2 mM; lanes 7, 14 and 21, 4 mM. LEDGF/p75 was omitted
from the reactions in lanes 1, 8 and 15. The migration positions of starting substrates, shifted complexes and slowly-migrating high molecular weight (HMW)
complexes are indicated. Similar results were obtained following multiple independent experiments. (E) Supershift experiment. LEDGF/p75 was omitted from the
reaction in lane 1. Lane 2 contained 2mM LEDGF/p75 and 100 nM Mut1 DNA. Lane 3, anti-LEDGF/p75 antibody was added 5 min after LEDGF/p75 and DNA. Lane
4, same as lane 3 except control IgG1 was substituted for the specific antibody. Results are representative of five independent supershift experiments.
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in real-time under native conditions like isotonic salt, and can
also detect transient interactions (33,34). Biotinylated sub-
strates were immobilized on to a streptavidin-coated sensor
chip, LEDGF/p75 was injected for 1 min at the sub-saturating
concentration of 25 nM, and protein dissociation was moni-
tored for 30 min by flowing running buffer over the chip
surface. Unexpectedly, LEDGF/p75 displayed near equal effi-
ciencies of binding to all three DNA substrates (Figure 1B).
DNA-binding was characterized by a relatively fast associa-
tion, followed by biphasic dissociation. LEDGF/p75 dissoci-
ated from DNA relatively quickly for 2 min, and then more
slowly, giving rise to stable binding after 15 min. Based on
kinetic measurements, LEDGF/p75 DNA interactions could
fit, though with significant residuals, to a simple 1:1 Langmuir
binding model. We were unable to observe any significant
difference between association/dissociation curves or apparent
dissociation constants for LEDGF/p75 binding to the different
substrates (Figure 1B and data not shown). Similar binding
characteristics were observed using a biotinylated 38 bp
oligonucleotide that modeled the U5 end of HIV-1 DNA.
We note that these results were independent of the LEDGF/
p75 purification procedure, as protein recovered via the use of
a His6 affinity tag (three total chromatographic steps;
Figure 1C, lane 2) as well as non-tagged LEDGF/p75 (four
chromatographic steps; Figure 1C, lane 1) displayed indistin-
guishable DNA-binding profiles to the HSE, Mut1 and Mut2
substrates.
Due to the discrepancy observed here with SPR and previ-
ous results that primarily used EMSA, we next assayed
LEDGF/p75 DNA-binding by gel-based methods. Protein
was incubated with non-biotinylated DNA substrates, and
reactions were fractionated through 4% MetaPhor agarose
gels (Figure 1D). As observed with SPR, each of the three
previously described substrates supported LEDGF/p75 DNA
complex formation. Faster-migrating (presumably lower
molecular weight) complexes were first observed with
250 ng LEDGF/p75 (Figure 1D, lanes 3, 10 and 17) and
better-defined, more slowly-migrating complexes were
observed at 2 and 4 mM protein (lanes 6, 7, 13, 14, 20 and
21). As was the case with SPR, the different preparations of
LEDGF/p75 protein yielded indistinguishable patterns of
DNA-binding (data not shown). Similar overall patterns of
DNA-binding were observed in 4.5% polyacrylamide gels,
though we note the formation of better-defined nucleoprotein
complexes in MetaPhor agarose.
The different preparations of wild-type LEDGF/p75 protein
used in these assays were 95 and 80% pure (Figure 1C,
lanes 1 and 2). Considering the use of different purification
procedures, we felt reasonably confident that the observed
DNA-binding was due to LEDGF/p75 and not a minor
co-purifying contaminant(s). To demonstrate specificity, a
supershift experiment was performed (Figure 1E). To enhance
the separation of potential high molecular weight complexes,
gel running times were increased from 2.5 to 7.5 h. At these
conditions, LEDGF/p75 yielded a heterogeneous population
of shifted complexes (compare lane 2 to lane 1). Importantly,
complex mobilities were retarded by an anti-LEDGF/p75
monoclonal antibody under conditions where migration posi-
tions were unaffected by an isotype control antibody (compare
lanes 2–4). Based on these observations as well as the identical
behavior of different protein preparations, we conclude that
SPR (Figure 1B) and EMSA (Figure 1D) detected LEDGF/p75
DNA-binding activity.
DNA-binding activity maps to residues 93–226
Deletion analysis was utilized to locate the region(s) of
LEDGF/p75 responsible for DNA-binding. Choices of protein
boundaries were based on previously defined conserved
sequences and functional domains (10,13–15). The PWWP
domain, encompassing the N-terminal 93 residues of
LEDGF/p75, is the most conserved part of the protein (15).
The other conserved domain, comprised of residues 347–429,
mediates binding to integrase (15,16,25,35) (Figure 2A).
Shorter stretches of conserved residues were also targeted.
Residues 146RRGRKRK152 comprise the NLS (16,19,36),
whereas residues 178–197 resemble two AT-hook DNA-
binding motifs (10,15) (see below). Four deletion mutant
proteins were constructed and purified to address the roles
of these elements in DNA-binding. The 1–116 fragment
contains the PWWP domain, and the C-terminal 347–530
fragment harbors the IBD (Figures 1C and 2A). Two internal
fragments, 93–325 and 93–226, contain the NLS and
AT-hooks (Figure 2A). Proteins were produced in bacteria
as fusions to GST, and the tags were removed prior to
DNA-binding assays (Figure 1C).
Figure 2. LEDGF/p75 residues 93–226 harbor DNA-binding activity. (A)
Schematic representation of wild-type LEDGF/p75 and deletion mutant pro-
teins. Conserved sequence motifs/functional domains are indicated above the
protein, with boundaries indicated below. NLS, nuclear localization signal;
IBD, integrase-binding domain. (B) DNA-binding activities of deletion mutant
proteins. DNA (100 nM Mut1) was reacted with the following protein con-
centrations: 250 nM (lanes 2, 5, 8, 11 and 14), 2mM (lanes 3, 6, 9, 12 and 15) or 5
mM (lanes 4, 7, 10, 13 and 16). LEDGF was omitted from the reaction in lane 1.
The results are representative of four independent gel shift experiments. The
migration positions of free DNA and nucleoprotein complexes are indicated.
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Neither the PWWP domain (Figure 2B, lanes 8–10) nor
the larger C-terminal 347–530 fragment (lanes 5–7) readily
bound to DNA, even at high protein concentrations. On
the contrary, internal fragments 93–325 and 93–226
shifted the DNA substrate, though we note initial complex
formation required more deletion mutant protein than
wild-type (compare lanes 11 and 14 to lane 2) and high
molecular weight complexes formed less efficiently than
with the wild-type. Akin to the full-length protein, 93–226
bound similarly to the HSE, Mut1 and Mut2 substrates
(data not shown). SPR analyses with this set of mutant proteins
yielded similar results (data not shown). We conclude that the
DNA-binding activity of LEDGF/p75 resides within residues
93–226, and by extension, that neither the PWWP domain nor
residues 347–530 contribute significantly to DNA-binding
function in vitro.
The NLS and both copies of the AT-hook mediate
DNA-binding
Based on the previous results, the NLS and putative AT-hook
motifs were mutagenized. The core AT-hook consensus
sequence is Pro-Arg-Gly-Arg-Pro (with RGRP being invari-
ant) (37). Figure 3A aligns this sequence to the putative
LEDGF/p75 AT-hook sequences; as the NLS was observed
to contain three of the four invariant residues, it was included
in the alignment. The second AT-hook (hereafter referred to
as AT2) contains 193PRGRP197, which precisely matches the
consensus sequence. AT1, though mismatched at the first Pro
position, contains 180RGRP183, which matches the four invari-
ant residues. The NLS, which harbors 147RGR149, substitutes
Lys-150 for the invariant Pro (Figure 3A, asterisk). We note
that Lys-150 plays a key role in NLS function (19).
Figure 3. The NLS and both AT-hooks mediate DNA-binding. (A) Alignment of invariant amino acids within human LEDGF/p75 AT2, AT1 and NLS sequences to
the AT-hook consensus motif. Of the five residues that comprise the motif, four (RGRP) are invariant (Inv) (37). Residues in LEDGF/p75 that match the consensus
sequence are underlined. Lys-150 within the NLS (marked by an asterisk) is essential for nuclear import (19). (B) Residues altered in MutL1–MutL5. Asterisks
indicate amino acid residues that are identical among human, chicken and frog LEDGF/p75 orthologs (15). Invariant NLS and AT-hook residues are underlined with
continuous and dotted lines, respectively. Mutated residues are in bold type. (C) MutL1–MutL5 activities, expressed as percent of wild-type DNA-binding. Error bars
represent the variation obtained from duplicate measurements.
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Based on these observations, the following full-length
LEDGF/p75 mutant proteins were constructed (Figure 3B
and Table 1). Each of the six basic residues within the NLS
was changed to Ser or Ala in MutL2. MutL4 and MutL5
contained Ala-Ala-Ala in place of Arg-Gly-Arg in the AT1
and AT2 consensus sequences, respectively. MutL3 combined
the MutL4 and MutL5 changes, whereas MutL1 contained a
total of 12 amino acid substitutions (MutL3 plus MutL2).
Proteins were expressed in bacteria as His6-tag fusions, and
tags were removed prior to DNA-binding assays (Figure 1C).
Each mutant protein was expressed and displayed purification
properties similar to wild-type LEDGF/p75, indicating that
the noted amino acid substitutions did not significantly affect
protein expression, stability or folding.
The level of mutant protein that remained stably bound to
Mut1 DNA after 20 min of dissociation was quantified by SPR,
and results were expressed as percentage of wild-type DNA-
binding activity (Figure 3C). Each of the five mutant proteins
dissociated from DNA significantly faster than wild-type, indi-
cating that the NLS and each AT-hook contributed to DNA-
binding. However, the respective contribution of each of these
elements to DNA-binding differed. MutL4 retained the most
function (45% of wild-type), revealing AT1 180RGR182 as
the least important of the three invariant sequences under these
conditions. MutL2 displayed about 20% of wild-type function,
whereas MutL5 retained about 13% residual DNA-binding
activity (Figure 3C). Based on these results, the contribution
of the three different elements to DNA-binding was ranked
AT2>NLS>AT1. The NLS-defective K150A point mutant
protein (19) displayed wild-type DNA-binding activity, indi-
cating that Lys-150 on its own does not supply critical DNA-
binding function (data not shown). Mutation of four additional
lysine residues surrounding the core AT2 sequence (positions
179, 189, 198 and 201; Figure 3B) did not further reduce the
residual activity of MutL5, indicating that invariant 194RGR196
residues are primarily responsible for AT2-mediated DNA
recognition.
The dual AT-hook mutant MutL3 (Figure 1C, lane 7) dis-
played about 7% of wild-type DNA-binding activity, revealing
an additive effect of combining separate AT1 and AT2 muta-
tions. The NLS and dual AT-hook mutant MutL1 (Figure 1C,
lane 6) harbored just 3% residual DNA-binding function
(Figure 3C). Similar results were obtained for the five full-
length LEDGF/p75 mutant proteins using HSE or Mut2 sub-
strate DNA in place of Mut1 (data not shown). Based on this,
we conclude that a tripartite motif comprised of the NLS and
both copies of the AT-hook mediates the binding of LEDGF/
p75 to DNA in vitro.
The PWWP domain, though dispensable for binding
to naked DNA in vitro, contributes to
chromatin-association in vivo
Results of in vitro assays discounted a major role for the
PWWP domain in binding to DNA (Figures 2B and
3C). The PWWP domain is found in more than 60 eukaryotic
proteins and where analyzed, appears to play a central role in
mediating interactions with chromatin (38,39). To analyze the
role of the PWWP domain as well as the NLS and AT-hook
motifs in the association of LEDGF/p75 with human chro-
matin, EGFP fusion proteins were visualized in interphase
and mitotic cells using laser-scanning microscopy. The fol-
lowing mutants were constructed for these analyses. MutL7
lacked the PWWP domain. MutL9 contained this change along
with the dual AT-hook changes. The NLS was additionally
altered in MutL8 (Table 1).
LEDGF/p75 displays a characteristic irregular intranuclear
distribution during interphase where it is in large part excluded
from nucleoli, and associates intimately with chromosomes
during mitosis (9–11,16) (Figures 4A and 5A). We reported
that transiently-expressed NLS mutants of LEDGF/p75
were excluded from nuclei at 24 h post-transfection, with
a small number of cells displaying the wild-type nuclear
distribution pattern (19). Herein, where measurements were
obtained 48 h post-transfection, EGFP-MutL2 (NLS-deficient)
mainly localized to cell nuclei, displaying the wild-type
intranuclear distribution pattern (data not shown). In accor-
dance with Vanegas et al. (16), the NLS mutant also concen-
trated on condensed chromosomes, indicating that nuclear
accumulation occurred through chromosomal capture during
open mitoses. Because of this design, the inability for a mutant
fusion protein to interact normally with chromatin was
primarily due to defects in chromatin-association as compared
to LEDGF/p75 nuclear import. EGFP-MutL3, with both
AT-hooks mutated, behaved as the wild-type fusion
protein in interphasic and mitotic cells (data not shown). In
contrast, EGFP-MutL1, with the NLS and both AT-hooks
mutated, distributed diffusively throughout interphase cells
(Figure 4B) and failed to concentrate onto condensed
chromosomes (Figure 5B). As the results of western blotting
revealed stable expression of full-length EGFP-MutL1
protein in these cells (Supplementary Figure 1), we infer
Table 1. LEDGF/p75 mutants
Mutant name Targeted region(s)a Mutations
MutL1 NLS, AT1, AT2 R146S, R147A, R149A, K150A, R151S, K152A, R180A, G181A, R182A, R194A, G195A, R196A
MutL2 NLS R146S, R147A, R149A, K150A, R151S, K152A
MutL3 AT1, AT2 R180A, G181A, R182A, R194A, G195A, R196A
MutL4 AT1 R180A, G181A, R182A
MutL5 AT2 R194A, G195A, R196A
MutL6 NLS, AT1, AT2, IBD R146S, R147A, R149A, K150A, R151S, K152A, R180A, G181A, R182A, R194A, G195A, R196A, D366N
MutL7 PWWP D1-92
MutL8 PWWP, NLS, AT1, AT2 D1-92, R146S, R147A, R149A, K150A, R151S, K152A, R180A, G181A, R182A, R194A, G195A, R196A
MutL9 PWWP, AT1, AT2 D1-92, R180A, G181A, R182A, R194A, G195A, R196A
aNLS, nuclear localization signal (residues 146–152); AT1, AT-hook motif 1 (residues 178–183); AT2, AT-hook motif 2 (residues 191–197); PWWP, PWWP domain
(residues 1–93); IBD, integrase-binding domain (residues 347–429) (15).
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that DNA-binding plays a central role in chromatin-binding
in vivo.
Proteins lacking the PWWP domain were expressed at sig-
nificantly higher levels than wild-type LEDGF/p75 or other
EGFP fusion proteins (Supplementary Figure 1). Because of
this, detailed information was gleaned by lowering the inten-
sity of the scanning laser or by visualizing cells expressing
relatively low levels of mutant protein (Figure 4C; similar
results obtained using either method). Similar to the wild-
type, nuclear EGFP-MutL7 primarily co-localized with
DNA (Figure 4A and C). Yet, the PWWP deletion mutant
signal appeared more diffuse, and nucleolar exclusion was
somewhat less pronounced, as compared to the wild-type
(Figure 4A and C; data not shown). Because EGFP-MutL7
efficiently interacted with mitotic chromosomes (Figure 5C),
we conclude that the PWWP domain by itself is not a dominant
determinant of chromatin-association. Additional mutant anal-
yses, however, revealed an important contribution to this
activity. EGFP-MutL9 (PWWP and dual AT-hook mutations)
distributed diffusively throughout interphasic nuclei
(Figure 4D) and did not effectively engage mitotic chromo-
somes (Figure 5D). Thus, although separate disruption of the
PWWP domain or AT-hooks did not detectably alter binding
to condensed chromosomes (Figure 5C and data not shown),
the combination of these changes did. To directly assess the
chromatin-binding potential of the PWWP domain, EGFP-
PWWP was analyzed. This protein, which was predominantly
nuclear during interphase (Figure 4F), interacted with mitotic
chromosomes (Figure 5F). Yet as a fraction of EGFP-PWWP
remained cytosolic during mitosis (Figure 5F), we conclude
that the PWWP domain interacts with condensed chromo-
somes less efficiently than does either wild-type LEDGF/
p75 or, more importantly, the MutL7 mutant lacking the
domain (Figure 5, compare panel F to panels A and C).
EGFP-MutL8, altered at the NLS in addition to the PWWP
domain and AT-hooks, localized exclusively to the cytoplasm
of interphasic cells (Figure 4E) and was predictably deficient
for binding to condensed chromosomes (Figure 5E). The
somewhat unexpected cytoplasmic localization of EGFP-
MutL8 was not due to loss of LEDGF/p75 epitopes, as only
full-length protein was detected by blotting with the anti-
EGFP antibody (Supplementary Figure 1). As leptomycin B
Figure 4. Distribution of wild-type and mutant LEDGF/p75 fusion proteins in
live cells. (A) Wild-type (WT) LEDGF/p75. Note the characteristic irregular
nucleoplasmic distribution and exclusion from nucleoli (9,11). These two cells,
not adjacent in the original image, were brought together to highlight the wild-
type phenotype. (B–F) Intracellular/nuclear distribution of the indicated
LEDGF mutant proteins. Two cells expressing relatively low levels of
EGFP-MutL7 were highlighted in panel C; part of a cell expressing higher
levels of mutant protein is seen at the upper edge in the first and third frames.
The other panels depict two to three cells that are representative of the total
population of transfected cells.
Figure 5. The PWWP domain, NLS and AT-hooks contribute to chromatin
interactions in vivo. (A–F) Cells undergoing mitosis were analyzed for expres-
sion of the indicated EGFP fusion protein and DNA content.
1670 Nucleic Acids Research, 2006, Vol. 34, No. 5
did not affect the intracellular distribution of EGFP-MutL8
(data not shown), the phenotype was independent of CRM1-
mediated nuclear export (40).
A minor role for DNA-binding in stimulating HIV-1
integrase activity
LEDGF/p75 potently stimulates the in vitro catalytic activities
of HIV-1 integrase (10). The interaction with integrase, medi-
ated through the IBD, is necessary though not sufficient for
activity (15,25). To investigate the potential contribution of
DNA-binding to integration co-factor function, purified mut-
ant proteins were tested in an in vitro integration assay along-
side wild-type LEDGF/p75. To facilitate quantitative read-out,
a previously described mini-HIV integration assay (30) was
adapted for real-time PCR. The published assay monitors the
integration of substrate DNA into a second mini-HIV mole-
cule, readily revealing the stimulatory effect of LEDGF/p75
(Figure 6A, compare lane 4 to lane 2). For real-time PCR, a
supercoiled plasmid lacking viral sequences was included in
Figure 6. The role of LEDGF/p75 DNA-binding in stimulating HIV-1 integration in vitro. (A) Efficient use of pTZ18U/PL as an integration target. Reactions in lanes
2, 4–8, 10 and 12–16 contained 0.6 mM integrase, whereas reactions in lanes 3–8 and 11–16 contained 0.2 mM of the indicated protein. Reactions in lanes 9–16
additionally contained pTZ18U/PL. The migration positions of mini-HIV substrate DNA, supercoiled (s.c.) pTZ18U/PL and strand transfer reaction products are
indicated. The migration pattern of the plasmid on its own is shown on the right; molecular mass standards are to the left. (B) Integrase (IN) alone, integration reaction
conducted with integrase alone. Other reactions additionally contained 0.2 mM of the indicated protein. Relative levels of integration activity were quantified by real-
time PCR; IN alone activity was arbitrarily set to 1.0. Error bars are variation obtained from duplicate real-time assays. Similar levels of wild-type and mutant
LEDGF/p75 activities were observed following independent sets of integration reactions.
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the reaction as an integration target. Preliminary experiments
revealed efficient use of pTZ18U/PL (Figure 6A, compare lane
12 to lanes 9–11) and parallel behavior of previously-assessed
LEDGF/p75 loss-of-function mutants (compare lanes 12–14
to lanes 4–6).
Real-time PCR results were quantified by comparing
control or mutant LEDGF/p75 activities to a standard curve
generated by serially diluting wild-type LEDGF/p75-
dependent integration products. With this design, wild-type
LEDGF/p75 was determined to stimulate HIV-1 integrase
activity 137-fold (Figure 6B). GST and RNase A, each of
which failed to stimulate integration based on gel analyses
(Figure 6A, lanes 7, 8, 15 and 16), revealed about 1.1 and
1.2% of wild-type LEDGF/p75 function, respectively (panel
B). In accordance with our previous report (25), the D366N
missense mutant, which failed to interact with HIV-1
integrase, was greatly impaired in its ability to stimulate
integration, revealing about 8% of wild-type function in the
quantitative assay (Figure 6).
Because the N-terminal deletion mutant MutL7 displayed
about 88% of wild-type function (Figure 6B), we conclude
that the PWWP domain does not play an important role
in integrase co-factor function in vitro. As the AT1 mutant
MutL4 (about 45% of wild-type DNA-binding; Figure 3C)
stimulated integrase as efficiently as wild-type (Figure 6B),
we conclude that wild-type levels of LEDGF/p75
DNA-binding are not required for maximal activity. This
conclusion was further bourn out by analyzing MutL3
(AT1/2 mutant) and MutL1 (NLS + AT1/2): whereas
MutL3 and MutL1 retained but 7 and 3% of wild-type
DNA-binding activity (Figure 3C), 63 and 41% of wild-
type LEDGF/p75 stimulatory function, respectively, was
observed (Figure 6B). Combining the D366N integrase knock-
out change with MutL1 DNA-binding mutations effectively
abrogated co-factor function (Figure 6B, MutL6; 1.1% of
wild-type activity). An N-terminal deletion mutant lacking the
PWWP domain, NLS and AT-hooks interestingly supported
about 51% of wild-type function (Figure 6B, 226–530). In
agreement with previous findings (15), further truncation
from the N-terminus of this fragment to residue 347 abolished
stimulation (Figure 6B; 1.0% of wild-type function), indicat-
ing that sequences that lie between LEDGF/p75 residues 226
and 347 play a role in HIV-1 co-factor function in vitro.
DISCUSSION
LEDGF/p75 and its smaller splice-variant LEDGF/p52 are
transcriptional co-activators that appear to function by inter-
acting with general transcriptional machinery (2). Like other
proteins involved in transcriptional regulation (41), LEDGF/
p75 contains extensive unstructured regions (15). The protein
harbors two 10 kDa conserved domains, the PWWP domain
and IBD (15). Shorter stretches of invariant residues also play
critical roles in LEDGF/p75 function: 146RRGRKRK152 define
the NLS (16,19,36) and here we demonstrate a role for two
AT-hook motifs in binding to DNA and to chromatin.
Identification and characterization of a novel
non-specific DNA-binding motif in LEDGF/p75
Using a combination of deletion and missense mutagenesis,
we determined that a tripartite motif comprised of the NLS and
two AT-hooks mediates the binding of LEDGF/p75 to DNA
in vitro (Figures 2B and 3C) and ranked the individual
elements AT2>NLS>AT1 in terms of their relative contribu-
tions to overall DNA-binding function (Figure 3C). Consistent
with these findings, the vast majority of NLS sequences
enriched in basic amino acids contribute to nucleic acid-
binding function (42,43).
The NLS and AT-hooks account for fully one-half
of all invariant residues between the PWWP domain
(residue 93) and residue 226 in LEDGF/p75 (Figure 3B)
(15). From this and sequence predictions programs (15), we
infer that the conserved tripartite DNA-binding element sits in
a relatively unstructured part of the protein. The brunt of
LEDGF/p75 is efficiently digested after short exposure to a
limited amount of trypsin, as the IBD and PWWP domain
resist proteolysis and accumulate over time (15). Including
DNA did not detectably alter the kinetics or extent of proteo-
lysis (data not shown), indicating that DNA-binding does
not induce significant structural rearrangements within
this or other regions of the protein. We suppose that
unstructured AT-hooks might assume crescent shapes upon
engaging minor grooves in DNA, as demonstrated
for AT-hooks 2 and 3 in high mobility group protein
A1 (HMGA1) (44). Although we demonstrate the importance
of invariant RGR motifs in both AT1 and AT2 function,
our results did not reveal significant affinity for AT-rich
DNA over other sequences (Figure 1A, B and D). SPR
revealed faster dissociation rates and less stable binding of
LEDGF/p75 to different DNA substrates when the concentra-
tion of salt was incrementally increased from 140 to 300 mM
(data not shown), suggesting that LEDGF/p75 might primarily
interact with DNA in vitro though electrostatic interactions.
Consistent with this interpretation, binding to single-stranded
DNA and RNA templates was detected by EMSA (data not
shown).
It is somewhat difficult to reconcile our observation
of sequence non-specific binding with results of previous
studies. Shinohara and colleagues (17) reported
that LEDGF/p75 specifically bound to nGAAn and
(T/A)GGGG(A/T) sequences in the promoter regions of
Hsp27 and aB-crystallin genes, respectively. Our substrates
were based on findings that changing GAA to TAA or AAA
within the consensus HSE prevented LEDGF/p75 binding
(17), a result we failed to recapitulate (Figure 1B and D).
Although we failed to detect sequence-specific binding
utilizing independent preparations of LEDGF/p75 protein,
we cannot rule-out that LEDGF/p75 might display specificity
for particular DNA sequences under certain experimental
conditions.
More recently, Singh et al. (36) reported that the PWWP
domain and two HTH-like motifs in the C-terminal region of
LEDGF/p75 mediate binding to STRE and HSE sequences,
respectively. Yet, our results indicate that highly-purified
PWWP domain (Figure 1C, lane 4) and C-terminal domain
(Figure 1C, lane 3) protein failed to significantly bind DNA
under conditions where purified 93–226 protein (Figure 1C,
lane 5), harboring the NLS and AT-hooks, readily shifted
DNA substrates (Figure 2B). As Singh et al. (36) utilized
single-step purification procedures and detected the migration
positions of recombinant deletion mutant proteins by western
blotting, we infer that the deletion variants manufactured
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herein were of greater biochemical purity. Consistent with our
findings, it was recently reported that the AT-hooks participate
in the interaction of LEDGF/p75 with chromatin in vivo (26).
Additionally, our previous sequence and structure-based anal-
yses failed to reveal evidence for HTH-like motifs within C-
terminal regions 421–442 and 471–492. Residues 412–428
form the C-terminal a helix of the pseudo HEAT repeat analo-
gous topology (PHAT) IBD both in solution (25) and as part of
a co-crystallized complex with HIV-1 integrase (35). HEAT
(named after Huntingtin, Elongation factor 3, A subunit of
phosphatase 2A, yeast PI3 kinase TOR) repeats mediate
protein–protein interactions (45), and NMR spectroscopy
failed to detect any stable secondary structure within residues
431–471 (25). Furthermore, we were unable to confirm
evidence for a HTH-like motif within residues 471–492
using either the PROF (46) or SMART (47) prediction
program. As internal fragments 93–226 and 93–325 bound
DNA less efficiently than the full-length protein
(Figure 2B), it seems the N- and/or C-terminal regions
could contribute to the overall affinity of LEDGF/p75 for
nucleic acid. If so, we conclude these affects are distinct
from direct DNA-binding.
The PWWP domain cooperates with the NLS and
AT-hooks to mediate chromatin-binding in vivo
The PWWP domain, present in more than 60 eukaryotic
proteins, is the most conserved region of LEDGF/
p75 (13,15). The Dnmt3a and Dnmt3b methyltransferase
enzymes have been most thoroughly studied in terms of
PWWP domain contribution(s) to DNA and chromatin-
binding activities. We found that the LEDGF/p75 PWWP
domain behaved similarly to the Dnmt3a domain, as neither
effectively bound to free DNA in vitro [Figure 2B and
ref. (38)]. In contrast, the Dnmt3b domain displayed
DNA-binding activity (38,48). Despite this difference, the
Dnmt3a and Dnmt3b domains each played a central role in
pericentric heterochromatin localization (38) and mutations
within the Dnmt3b domain prevented the binding of full-
length enzyme to condensed chromosomes (39).
Based on the phenotypes of EGFP fusion proteins in
transfected cells, we propose that the PWWP domain works
in concert with the NLS and AT-hook motifs to mediate the
association of LEDGF/p75 with chromatin in vivo. The
PWWP deletion mutant MutL7 interacted normally with con-
densed chromosomes (Figure 5C), though we noted a subtle
difference in nucleoplasmic localization (Figure 4C). The dual
AT-hook mutant MutL3 displayed the wild-type chromatin-
interaction pattern, whereas the tripartite PWWP/AT-hook
MutL9 (Table 1) mutant failed to effectively engage mitotic
chromosomes (Figure 5D). As EGFP-PWWP remained par-
tially cytosolic under conditions wherein the PWWP deletion
MutL7 bound to mitotic chromosomes indistinguishably from
the wild-type (Figure 5A, C and F), we conclude that DNA-
binding likely imparts the dominant chromatin-association
function in vivo. It is clear that the PWWP domain contributes
to this activity but unlike Dnmt3b, it is not the dominant
determinant [Figure 5C and ref. (39)]. Our results agree
with and extend previous suggestions (14,38) that the
PWWP domain is likely to mediate protein interaction(s)
with chromatin.
DNA-binding activity plays a minor role in HIV-1
co-factor function in vitro
A variety of cellular factors have been reported to stimulate
HIV-1 integration, and the proteins can be divided into two
broad classes based on their propensity to bind integrase. For
example, integrase-interactor 1 (49) and LEDGF/p75 bind to
integrase and, at least in the latter case, integrase-binding is
essential for co-factor function in vitro (15,25) (Figure 6).
Other potential integration co-factors such as the barrier-to-
autointegration factor (50) and HMGA1 (51) appear to lack
affinity for retroviral integrases (52,53) and instead stimulate
integration mainly through their ability to bind DNA [(28,54);
for review see ref. (22,55)]. The IBD is necessary but not
sufficient to stimulate integrase activity in vitro (15,25), so
an outstanding question was the contribution of LEDGF/p75
DNA-binding activity to this process.
The tripartite DNA-binding mutant protein MutL1 was
about 2.5-fold reduced for integrase stimulation under condi-
tions where the D366N interaction-impaired mutant was about
12.5-fold defective (Figure 6B). From these data we conclude
that DNA-binding plays a modest role in stimulating integrase
activity and, by extension, that integrase-binding is 5-fold
more important than DNA-binding under these assay condi-
tions. Furthermore, the 226–530 fragment lacking the PWWP
domain, NLS and AT-hooks supported about 51% of wild-type
LEDGF/p75 function in vitro (Figure 6B). The isolated IBD
(residues 347–471; Figure 6A) and somewhat larger 347–530
fragment (Figure 6B) did not appreciably stimulate integrase
activity, indicating that residues between 226 and 347 play a
role in integrase co-factor function in vitro. What function
might this region contribute? The region is fairly well-
conserved across LEDGF/p75 orthologs, harboring 50 invari-
ant residues that mainly cluster into small groupings (15).
Although nearly half the invariant residues are lysine
(15,36), fragments encompassing residues 226–347 or 226–
283 did not detectably bind to DNA in vitro. Additional
experiments will be required to address the role of this region
in stimulating integrase activity in vitro as well as in other
LEDGF/p75 functions. As the AT-hooks were recently impli-
cated in targeting HIV-1 integration to active gene regions and
A/T-rich DNA sequences in vivo (26), our results indicate that
viral integration targeting is in large part independent of
LEDGF/p75’s ability to stimulate integrase catalytic function
in vitro.
CONCLUSIONS
Though established to bind to DNA in vitro and interact with
chromatin in cells, the regions and residues of LEDGF/p75
that mediate chromatin-association were unknown. In this
work, we define a novel tripartite DNA-binding element com-
prised of the NLS and two copies of the AT-hook motif that
mediates the binding of LEDGF/p75 to DNA, which, together
with our previous sequence and structure-based analyses, casts
doubt on recent claims for the PWWP domain and two C-
terminal HTH-like motifs in directing sequence-specific
DNA-binding activity. We also showed that DNA-binding
contributes a dominant function to chromatin-binding in
cells, with a likely PWWP domain-mediated protein interac-
tion playing more of a modulatory role than observed in
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previously analyzed systems. In contrast, DNA-binding plays
only a modest role in stimulating HIV-1 integrase activity in
vitro. Our results uncovered essential elements of LEDGF/p75
function, a transcriptional co-activator implicated in a variety
of human diseases including autoimmunity, cancer and AIDS.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
Funding for this work and to cover Open Access publication
charges for this article were provided by US NIH grants
AI39394 and AI52014. Core facilities were supported by a
Center for AIDS Research grant (AI60354) and the Dana-
Farber Cancer Institute/Harvard Cancer Center.
Conflict of interest statement. None declared.
REFERENCES
1. Spiegelman,B.M. and Heinrich,R. (2004) Biological control through
regulated transcriptional coactivators. Cell, 119, 157–167.
2. Ge,H., Si,Y. and Roeder,R.G. (1998) Isolation of cDNAs encoding
novel transcription coactivators p52 and p75 reveals an alternate
regulatory mechanism of transcriptional activation. EMBO J., 17,
6723–6729.
3. Shinohara,T., Singh,D.P. and Fatma,N. (2002) LEDGF, a survival factor,
activates stress-related genes. Prog. Retin. Eye Res., 21, 341–358.
4. Wu,X., Daniels,T., Molinaro,C., Lilly,M.B. and Casiano,C.A. (2002)
Caspase cleavage of the nuclear autoantigen LEDGF/p75 abrogates its
pro-survival function: implications for autoimmunity in atopic disorders.
Cell Death Differ., 9, 915–925.
5. Daniels,T., Zhang,J., Gutierrez,I., Elliot,M.L., Yamada,B., Heeb,M.J.,
Sheets,S.M., Wu,X. and Casiano,C.A. (2005) Antinuclear autoantibodies
in prostate cancer: immunity to LEDGF/p75, a survival protein highly
expressed in prostate tumors and cleaved during apoptosis. Prostate, 62,
14–26.
6. Ahuja,H.G., Hong,J., Aplan,P.D., Tcheurekdjian,L., Forman,S.J. and
Slovak,M.L. (2000) t(9;11)(p22;p15) in acute myeloid leukemia results in
a fusion between NUP98 and the gene encoding transcriptional
coactivators p52 and p75-lens epithelium-derived growth factor
(LEDGF). Cancer Res., 60, 6227–6229.
7. Hussey,D.J., Moore,S., Nicola,M. and Dobrovic,A. (2001) Fusion of the
NUP98 gene with the LEDGF/p52 gene defines a recurrent acute myeloid
leukemia translocation. BMC Genet., 2, 20.
8. Grand,F.H., Koduru,P., Cross,N.C. and Allen,S.L. (2005)
NUP98-LEDGF fusion and t(9;11) in transformed chronic myeloid
leukemia. Leuk. Res., 29, 1469–1472.
9. Nishizawa,Y., Usukura,J., Singh,D.P., Chylack,L.T.J. and Shinohara,T.
(2001) Spatial and temporal dynamics of two alternatively spliced
regulatory factors, lens epithelium-derived growth factor (ledgf/p75) and
p52, in the nucleus. Cell Tissue Res., 305, 107–114.
10. Cherepanov,P., Maertens,G., Proost,P., Devreese,B., Van Beeumen,J.,
Engelborghs,Y., De Clercq,E. and Debyser,Z. (2003) HIV-1 integrase
forms stable tetramers and associates with LEDGF/p75 protein in human
cells. J. Biol. Chem., 278, 372–381.
11. Maertens,G., Cherepanov,P., Pluymers,W., Busschots,K., De Clercq,E.,
Debyser,Z. and Engelborghs,Y. (2003) LEDGF/p75 is essential for
nuclear and chromosomal targeting of HIV-1 integrase in human cells.
J. Biol. Chem., 278, 33528–33539.
12. Ganapathy,V. and Casiano,C.A. (2004) Autoimmunity to the nuclear
autoantigen DFS70 (LEDGF): what exactly are the autoantibodies trying
to tell us? Arthritis Rheum., 50, 684–688.
13. Izumoto,Y., Kuroda,T., Harada,H., Kishimoto,T. and Nakamura,H.
(1997) Hepatoma-derived growth factor belongs to a gene family in mice
showing significant homology in the amino terminus. Biochem. Biophys.
Res. Commun., 238, 26–32.
14. Stec,I., Nagl,S.B., van Ommen,G.-J.B. and den Dunnen,J.T. (2000)
The PWWP domain: a potential protein–protein interaction domain
in nuclear proteins influencing differentiation? FEBS Letters, 473, 1–5.
15. Cherepanov,P., Devroe,E., Silver,P.A. and Engelman,A. (2004)
Identification of an evolutionarily-conserved domain in LEDGF/p75 that
binds HIV-1 integrase. J. Biol. Chem., 279, 48883–48892.
16. Vanegas,M., Llano,M., Delgado,S., Thompson,D., Peretz,M. and
Poeschla,E. (2005) Identification of the LEDGF/p75 HIV-1
integrase-interaction domain and NLS reveals NLS-independent
chromatin tethering. J. Cell Sci., 118, 1733–1743.
17. Singh,D.P., Fatma,N., Kimura,A., Chylack,J., Leo,T. and Shinohara,T.
(2001) LEDGF binds to heat shock and stress-related element to activate
the expression of stress-related genes. Biochem. Biophys. Res. Comm.,
283, 943–955.
18. Busschots,K., Vercammen,J., Emiliani,S., Benarous,R., Engelborghs,Y.,
Christ,F. and Debyser,Z. (2005) The interaction of LEDGF/p75 with
integrase is lentivirus-specific and promotes DNA binding.J. Biol. Chem.,
280, 17841–17847.
19. Maertens,G., Cherepanov,P., Debyser,Z., Engelborghs,Y. and
Engelman,A. (2004) Identification and characterization of a functional
nuclear localization signal in the HIV-1 integrase interactor LEDGF/p75.
J. Biol. Chem., 279, 33421–33429.
20. Aravind,L. and Landsman,D. (1998) AT-hook motifs identified in a wide
variety of DNA-binding proteins. Nucleic Acids Res., 26, 4413–4421.
21. Llano,M., Vanegas,M., Fregoso,O., Saenz,D., Chung,S., Peretz,M. and
Poeschla,E.M. (2004) LEDGF/p75 determines cellular trafficking of
diverse lentiviral but not murine oncoretroviral integrase proteins and is a
component of functional lentiviral preintegration complexes. J. Virol., 78,
9524–9537.
22. Turlure,F., Devroe,E., Silver,P.A. and Engelman,A. (2004) Human cell
proteins and human immunodeficiency virus DNA integration. Front.
Biosci., 9, 3187–3208.
23. Bradley,C.M. and Craigie,R. (2005) Seeing is believing: structure of the
catalytic domain of HIV-1 integrase in complex with human LEDGF/p75.
Proc. Natl Acad. Sci. USA, 102, 17543–17544.
24. Emiliani,S., Mousnier,A., Busschots,K., Maroun,M., Van Maele,B.,
Tempe,D., Vandekerckhove,L., Moisant,F., Ben-Slama,L., Witvrouw,M.
et al. (2005) Integrase mutants defective for interaction with LEDGF/p75
are impaired in chromosome tethering and HIV-1 replication. J. Biol.
Chem., 280, 25517–25523.
25. Cherepanov,P., Sun,Z.-Y.J., Rahman,S., Maertens,G., Wagner,G. and
Engelman,A. (2005) Solution structure of the HIV-1 integrase-
binding domain in LEDGF/p75. Nature Struct. Mol. Biol., 12, 526–532.
26. Ciuffi,A., Llano,M., Poeschla,E., Hoffmann,C., Leipzig,J., Shinn,P.,
Ecker,J.R. and Bushman,F. (2005) A role for LEDGF/p75 in targeting
HIV DNA integration. Nature Med., 11, 1287–1289.
27. Vandegraaff,N., Devroe,E., Turlure,F., Silver,P.A. and Engelman,A.
(2006) Biochemical and genetic analyses of integrase-interacting proteins
lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-
derived growth factor related protein 2 (HRP2) in preintegration complex
function and HIV-1 replication. Virology, 346, 415–426.
28. Harris,D. and Engelman,A. (2000) Both the structure and DNA binding
function of the barrier-to-autointegration factor contribute to
reconstitution of HIV type 1 integration in vitro. J. Biol. Chem., 275,
39671–39677.
29. Goldhaber-Gordon,I., Early,M.H. and Baker,T.A. (2003) The terminal
nucleotide of the Mu genome controls catalysis of DNA strand transfer.
Proc. Natl Acad. Sci. USA, 100, 7509–7514.
30. Cherepanov,P., Surratt,D., Toelen,J., Pluymers,W., Griffith,J., De
Clercq,E. and Debyser,Z. (1999) Activity of recombinant HIV-1 integrase
on mini-HIV DNA. Nucleic Acids Res., 27, 2202–2210.
31. Dorfman,T., Luban,J., Goff,S.P., Haseltine,W.A. and Gottlinger,H.G.
(1993) Mapping of functionally important residues of a cysteine-histidine
box in the human immunodeficiency virus type 1 nucleocapsid protein.
J. Virol., 67, 6159–6169.
32. Fatma,N., Singh,D.P., Shinohara,T. and Chylack,L.T.,Jr (2001)
Transcriptional regulation of the antioxidant protein 2 gene, a
thiol-specific antioxidant, by lens epithelium-derived growth factor to
protect cells from oxidative stress. J. Biol. Chem., 276, 48899–48907.
33. Malmqvist,M. (1999) BIACORE: an affinity biosensor system for
characterization of biomolecular interactions. Biochem. Soc. Trans., 27,
335–340.
1674 Nucleic Acids Research, 2006, Vol. 34, No. 5
34. Rich,R.L. and Myszka,D.G. (2001) BIACORE J: a new platform for
routine biomolecular interaction analysis. J. Mol. Recognit., 14, 223–228.
35. Cherepanov,P., Ambrosio,A.L.B., Rahman,S., Ellenberger,T. and
Engelman,A. (2005) From the Cover: structural basis for the recognition
between HIV-1 integrase and transcriptional coactivator p75. Proc. Natl
Acad. Sci. USA, 102, 17308–17313.
36. Singh,D.P., Kubo,E., Takamura,Y., Shinohara,T., Kumar,A.,
Chylack,L.T.J. and Fatma,N. (2006) DNA binding domains and nuclear
localization signal of LEDGF: contribution of two helix-turn-helix
(HTH)-like domains and a stretch of 58 amino acids of the N-terminal to
the trans-activation potential of LEDGF. J. Mol. Biol., 355, 379–394.
37. Reeves,R. (2001) Molecular biology of HMGA proteins: hubs of nuclear
function. Gene, 277, 63–81.
38. Chen,T., Tsujimoto,N. and Li,E. (2004) The PWWP domain of Dnmt3a
and Dnmt3b is required for directing DNA methylation to the major
satellite repeats at pericentric heterochromatin. Mol. Cell. Biol., 24,
9048–9058.
39. Ge,Y.-Z., Pu,M.-T., Gowher,H., Wu,H.-P., Ding,J.-P., Jeltsch,A. and
Xu,G.-L. (2004) Chromatin targeting of de novo DNA methyltransferases
by the PWWP domain. J. Biol. Chem., 279, 25447–25454.
40. Yoshida,M. and Horinouchi,S. (1999) Trichostatin and leptomycin:
inhibition of histone deacetylation and signal-dependent nuclear export.
Ann. N.Y. Acad. Sci., 886, 23–35.
41. Liu,J., Tan,H. and Rost,B. (2002) Loopy proteins appear conserved in
evolution. J. Mol. Biol., 322, 53–64.
42. LaCasse,E.C. and Lefebvre,Y.A. (1995) Nuclear localization signals
overlap DNA- or RNA-binding domains in nucleic acid-binding proteins.
Nucleic Acids Res., 23, 1647–1656.
43. Cokol,M., Nair,R. and Rost,B. (2000) Finding nuclear localization
signals. EMBO Rep., 1, 411–415.
44. Huth,J.R., Bewley,C.A., Nissen,M.S., Evans,J.N., Reeves,R.,
Gronenborn,A.M. and Clore,G.M. (1997) The solution structure of an
HMG-I(Y)-DNA complex defines a new architectural minor groove
binding motif. Nature Struct. Biol., 4, 657–665.
45. Andrade,M.A., Petosa,C., O’Donoghue,S.I., Muller,C.W. and Bork,P.
(2001) Comparison of ARM and HEAT protein repeats. J. Mol. Biol., 309,
1–18.
46. Rost,B. (1996) PHD: predicting one-dimensional protein structure by
profile-based neural networks. Methods Enzymol., 266, 283–296.
47. Letunic,I., Copley,R.R., Schmidt,S., Ciccarelli,F.D., Doerks,T.,
Schultz,J., Ponting,C.P. and Bork,P. (2004) SMART 4.0: towards
genomic data integration. Nucleic Acids Res., 32, D142–D144.
48. Qiu,C., Sawada,K., Zhang,X. and Cheng,X. (2002) The PWWP domain of
mammalian DNA methyltransferase Dnmt3b defines a new family of
DNA-binding folds. Nature Struct. Biol., 9, 217–224.
49. Kalpana,G.V., Marmon,S.,Wang,W., Crabtree,G.R. andGoff,S.P. (1994)
Binding and stimulation of HIV-1 integrase by a human homolog of yeast
transcription factor SNF5. Science, 266, 2002–2006.
50. Lee,M.S. and Craigie,R. (1998) A previously unidentified host protein
protects retroviral DNA from autointegration. Proc. Natl Acad. Sci. USA,
95, 1528–1533.
51. Farnet,C.M. and Bushman,F.D. (1997) HIV-1 cDNA integration:
requirement of HMG I(Y) protein for function of preintegration
complexes in vitro. Cell, 88, 483–492.
52. Hindmarsh,P., Ridky,T., Reeves,R., Andrake,M., Skalka,A.M. and
Leis,J. (1999) HMG protein family members stimulate human
immunodeficiency virus type 1 and avian sarcoma virus concerted DNA
integration in vitro. J. Virol., 73, 2994–3003.
53. Mansharamani,M., Graham,D.R.M., Monie,D., Lee,K.K.,
Hildreth,J.E.K., Siliciano,R.F. and Wilson,K.L. (2003)
Barrier-to-autointegration factor BAF binds p55 Gag and matrix and
is a host component of human immunodeficiency virus type 1 virions.
J. Virol., 77, 13084–13092.
54. Li,L., Yoder,K., Hansen,M.S.T., Olvera,J., Miller,M.D. and
Bushman,F.D. (2000) Retroviral cDNA integration: stimulation by HMG
I family proteins. J. Virol., 74, 10965–10974.
55. Engelman,A. (2003) The roles of cellular factors in retroviral integration.
Curr. Top. Microbiol. Immunol., 281, 209–238.
Nucleic Acids Research, 2006, Vol. 34, No. 5 1675
